Published in Scand J Gastroenterol on July 01, 1997
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06
Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47
Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut (2001) 1.27
Corpus gastritis is protective against reflux oesophagitis. Gut (1999) 1.23
The time to eradicate gastric cancer is now. Gut (2005) 1.22
Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med (2000) 0.99
Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr (2003) 0.97
Gastric hyposecretion in esophageal squamous-cell carcinomas. Dig Dis Sci (2009) 0.93
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89
Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut (2006) 0.88
Helicobacter pylori is not and never was "protective" against anything, including GERD. Dig Dis Sci (2003) 0.86
Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan. BMC Gastroenterol (2009) 0.85
Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun (1999) 0.84
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders. Dig Dis Sci (2003) 0.84
Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis (2008) 0.84
Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci (2005) 0.83
The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study. United European Gastroenterol J (2013) 0.81
Haematological response to iron supplementation is reduced in children with asymptomatic Helicobacter pylori infection. Br J Nutr (2005) 0.81
Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol (2009) 0.81
Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol (2009) 0.80
No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci (2001) 0.77
The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract. Prz Gastroenterol (2014) 0.76
Helicobacter pylori and maximal acid output in chronic gastritis. Scand J Gastroenterol (1997) 0.75
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Dig Dis Sci (2003) 0.75
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Norwalk virus genome cloning and characterization. Science (1990) 5.83
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20
N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci U S A (2001) 2.71
Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67
A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Frequency of positive tests for cytomegalovirus in AIDS patients: endoscopic lesions compared with normal mucosa. Am J Gastroenterol (1993) 2.63
Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54
Rotavirus stability and inactivation. J Gen Virol (1979) 2.48
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43
Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38
Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37
Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36
Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29
Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16
Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10
Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology (1987) 2.07
Nucleic acid hybridization studies of mycobactin-dependent mycobacteria. J Clin Microbiol (1988) 2.06
Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94
Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol (2001) 1.93
Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch (1998) 1.91
Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol (1996) 1.89
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88
Biochemical mapping of the simian rotavirus SA11 genome. J Virol (1983) 1.88
Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther (2012) 1.87
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85
Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics (1991) 1.82
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol (1996) 1.81
Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology (1980) 1.81
Ultrastructural study of rotavirus replication in cultured cells. J Gen Virol (1980) 1.81
Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol (1987) 1.80
The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol (1990) 1.79
Simian rotavirus SA11 replication in cell cultures. J Virol (1979) 1.79
Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc (1995) 1.78
Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol (1990) 1.78
Aspirin and the stomach. Ann Intern Med (1986) 1.77
Detection of antigenically distinct rotaviruses from infants. Infect Immun (1983) 1.77
Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol (1999) 1.76
The molecular epidemiology of rotavirus gastroenteritis. Prog Med Virol (1984) 1.74
Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology (1992) 1.74
Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology (1989) 1.74
The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann Intern Med (1993) 1.73
Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut (1999) 1.72
Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci (2000) 1.71
Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med (1991) 1.68
Toothpick perforation of the intestines. Ann Surg (1977) 1.67
Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol (1992) 1.67
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med (2001) 1.66
Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med (2001) 1.65
Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol (1999) 1.65
How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol (1998) 1.64